Journal article
Role of metadherin in estrogen-regulated gene expression
International journal of molecular medicine, Vol.40(2), pp.303-310
08/2017
DOI: 10.3892/ijmm.2017.3020
PMCID: PMC5504974
PMID: 28627585
Abstract
The disruption of estrogen signaling is widely associated with the development of breast, endometrial and ovarian cancers. As a multifunctional mediator of carcinogenesis, metadherin (MTDH)/astrocyte elevated gene-1 (AEG-1) overexpression has been associated with numerous types of cancer, with reported roles in tumor initiation, proliferation, invasion, metastasis and chemoresistance. At the molecular level, MTDH has been shown to interact with proteins that drive tumorigenesis, including nuclear factor-κB (NF-κB), promyelocytic leukaemia zinc finger (PLZF), BRCA2- and CDKN1A (p21Cip1/Waf-1/mda-6)-interacting protein α (BCCIPα) and staphylococcal nuclease and tudor domain containing 1 (SND1). Through the analysis of the Cancer Genome Atlas (TCGA) datasets for estrogen receptor (ER)-positive endometrial and breast cancers, we found that over 25% of all gene expression correlated with MTDH. Using Affymetrix microarrays, we characterized the differences in gene expression between estrogen-treated parental and MTDH-deficient endometrial and breast cancer cells. We also explored a possible interaction between MTDH and ER by immunoprecipitation, and found that MTDH and ER associated in both breast and endometrial cancer cells in response to estrogen. Reciprocal co-immunoprecipitation analysis demonstrated that acute estrogen stimulation promoted the interaction of MTDH with ER in the nucleus. These data, to the best of our knowledge, provide the first evidence that MTDH and ERα interact in the nucleus with estrogen treatment to regulate gene expression.
Details
- Title: Subtitle
- Role of metadherin in estrogen-regulated gene expression
- Creators
- Yujun Li - Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USAJesus Gonzalez Bosquet - Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USAShujie Yang - Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USAKristina W Thiel - Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USAYuping Zhang - Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USAHaitao LiuKimberly K Leslie - Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USAXiangbing Meng - Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA 52242, USA
- Resource Type
- Journal article
- Publication Details
- International journal of molecular medicine, Vol.40(2), pp.303-310
- DOI
- 10.3892/ijmm.2017.3020
- PMID
- 28627585
- PMCID
- PMC5504974
- NLM abbreviation
- Int J Mol Med
- ISSN
- 1107-3756
- eISSN
- 1791-244X
- Publisher
- Greece
- Grant note
- R01 CA099908 / NCI NIH HHS P30 CA086862 / NCI NIH HHS R01 CA184101 / NCI NIH HHS
- Language
- English
- Date published
- 08/2017
- Academic Unit
- Pathology; Obstetrics and Gynecology
- Record Identifier
- 9983931207702771
Metrics
27 Record Views